EJMC-1(Cat No.:I043528)is a small molecule compound being explored for its potential in cancer therapy. It acts as an inhibitor targeting key molecular pathways involved in tumor cell growth and survival. Although specific details of its mechanism of action are still being investigated, EJMC-1 shows promise in disrupting cellular processes that contribute to cancer progression. Early research suggests that EJMC-1 could be effective in treating cancers with resistance to conventional therapies. Ongoing clinical studies aim to determine its safety, efficacy, and potential for broader use in oncology treatment regimens.